|
71 |
Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
Enthalten in Quality of life research Bd. 31, 18.8.2022, Nr. 11, date:11.2022: 3253-3266
|
|
|
|
72 |
Oligosarcomas, IDH-mutant are distinct and aggressive
Enthalten in Acta neuropathologica Bd. 143, 30.12.2021, Nr. 2, date:2.2022: 263-281
|
|
|
|
73 |
Outcome analysis for patients with subarachnoid hemorrhage and vasospasm including endovascular treatment
Enthalten in Neurological research and practice Bd. 5, 2.11.2023, Nr. 1, date:12.2023: 1-10
|
|
|
|
74 |
Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept
Enthalten in BMC cancer Bd. 10, 23.8.2010, Nr. 1, date:12.2010: 1-10
|
|
|
|
75 |
Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee
Enthalten in BMC cancer Bd. 20, 12.5.2020, Nr. 1, date:12.2020: 1-10
|
|
|
|
76 |
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study
Enthalten in Acta Neuropathologica Communications Bd. 10, 3.1.2022, Nr. 1, date:12.2022: 1-14
|
|
|
|
77 |
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival
Enthalten in Acta Neuropathologica Communications Bd. 10, 10.1.2022, Nr. 1, date:12.2022: 1-10
|
|
|
|
78 |
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
Enthalten in Acta neuropathologica Bd. 136, 2.7.2018, Nr. 2, date:8.2018: 181-210
|
|
|
|
79 |
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
Enthalten in Radiation oncology Bd. 6, 13.9.2011, Nr. 1, date:12.2011: 1-5
|
|
|
|
80 |
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors
Enthalten in Nature medicine Bd. 31, 25.3.2025, Nr. 5, date:5.2025: 1567-1577
|
|
Administration
